An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC

NCT07482891 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting

Interventions

DRUG: Fosrolapitant and Palonosetron Hydrochloride for Injection
DRUG: Dexamethasone
DRUG: Olanzapine

Sponsor

Shanghai 6th People's Hospital